This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 1994.
Company Filing History:
Years Active: 1994
Title: Bruce M. Travis: Innovator in HIV Research
Introduction
Bruce M. Travis is a notable inventor based in King, Washington. He has made significant contributions to the field of immunology, particularly in the study of Human Immunodeficiency Virus (HIV). His innovative work has led to advancements in the detection and understanding of this critical virus.
Latest Patents
Bruce M. Travis holds a patent for the "Expression of immunologically reactive HIV envelope proteins." This patent describes a method for expressing proteins that are immunologically reactive with antibodies to lymphadenopathy-associated virus (LAV), now known as HIV. The proteins are produced by bacterial host cells transformed with a recombinant plasmid that includes appropriate procaryotic transcriptional and translational signals for expression. This method allows for the production of proteins that can be used to screen for the presence of antibodies to LAV in biological fluids, determine the presence of LAV antigen, or produce antibodies to LAV through immunization of an animal with the protein.
Career Highlights
Bruce M. Travis is associated with Bristol-Myers Squibb Company, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of HIV and developing methods for its detection and treatment.
Collaborations
Throughout his career, Bruce has collaborated with notable colleagues, including Susan McArdle and Suan M. Watanabe. These collaborations have further enriched his research and contributed to the scientific community's understanding of HIV.
Conclusion
In summary, Bruce M. Travis is a distinguished inventor whose work in HIV research has had a profound impact on the field. His innovative methods for expressing immunologically reactive proteins continue to play a vital role in the fight against HIV.